Index of reports
> Cases with Hydronephrosis (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prandin (Repaglinide) where reactions include hydronephrosis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Prandin side effects in female
Reported by a physician from Korea, Republic of on 2012-03-20
Patient: female, weighing 46.1 kg (101.4 pounds)
Reactions: Hydronephrosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prandin
Dosage: 6 mg, bid
Administration route: Oral
Indication: Immunosuppression
Start date: 2012-01-22
Sandimmune
Dosage: 175 mg, qd
Administration route: Oral
Indication: Immunosuppression
Start date: 2012-01-17
Certican
Dosage: 1.5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2011-02-17
|